StreetAlpha.app
Home › Stocks › CALC

CalciMedica, Inc. (CALC)

$1.22
▲ +2.52%
LAST CLOSE · NOV 17

CalciMedica develops drug candidates that block CRAC channels to treat serious inflammatory and immune conditions. It last closed at $1.22 on Nov 17, up 2.52% on the day.

AI Auto Pilots
Is CALC in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Net income
−$15.1M
Free cash flow
−$18.2M
Valuation
Market cap
$8.4M
6.9M shares
P/E
–
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$4.6M
At Sep 30
Shareholder equity
$4.2M
Shares outstanding
6.9M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$35.8M−$35.8MFY2021FY2022: −$7.8M−$7.8MFY2022FY2023: −$34.4M−$34.4MFY2023FY2024: −$13.7M−$13.7MFY2024FY2025: −$29.6M−$29.6MFY2025

From CALC's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Last report
Nov 10
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated CALC in the past 90 days, not enough for a consensus
Average 12-month target
$9.00
▲ 637.7% upside

Based on 1 analyst who set a price target on CALC in the past 90 days. The average target is $9.00, with a high of $9.00 and a low of $9.00, compared with the last close of $1.22.

Low $9.00Avg $9.00High $9.00
Blue marker: last close $1.22
Highest target$9.00
Average target$9.00
Lowest target$9.00
Latest rating changes
GuggenheimInitiated
Aug 20Buy$9
DateFirmActionRatingPrice target
Aug 20GuggenheimInitiatedBuy$9
Loading…

Technical Analysis

CALC · as of the Nov 17 close · updated after every close
Downtrend

The stock is 10% below its 20 day and 23% below its 50 day average. It is 142% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 43). The nearest support is the Pivot S1 at $1.18, and the nearest resistance the Pivot at $1.23.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 14.8%/day
Key levels
$36.0052 week high+2850.8%
$2.95200 day average+141.8%
$2.52100 day average+106.6%
$1.61Swing high (Nov 9)+32.0%
$1.5050 day average+23.0%
$1.3420 day average+9.8%
$1.28Pivot R1+4.9%
$1.23Pivot+0.8%
$1.22Last close
$1.18Pivot S1−3.3%
$1.16Swing low (Nov 5)−4.9%
$1.0052 week low−18.0%
Indicators
RSI (14)42.89Middle of its rangeNeutral
MACD-0.07Below its signal lineBearish
Stochastic8.6Near the bottom of its rangeOversold
ADX (14)21.1Weak trend
Williams %R-88.6Oversold below −80, overbought above −20Oversold
CCI (20)-69.3Oversold below −100, overbought above 100Neutral
Rate of change−17.0%Change over 10 sessionsBearish
ATR (14)$0.18Typical daily range, 14.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CALC

What happened before

See how CALC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow CALC usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How CALC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2023.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in CALC in the last 90 days.

Loading…

See today’s whale options flow across the market →

CALC Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bearish
Strongly bearishNeutralStrongly bullish
  • ▼17 buying vs 31 selling
  • ▼Held by funds -97.0 pts
  • ▼Funds holding -14
  • ▼Superinvestors: 0 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding1731−45.2%
In funds' top 1000–
Held by funds24.5%121.6%−97.0 pts
New / increased17 / 010 / 5+13.3%
Reduced / sold out0 / 317 / 6+138.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CALC institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CALC is in one of them and how their past CALC trades turned out.

CALC in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CALC in an article yet. Here's the latest on the wider market.

About CalciMedica

CalciMedica is a biopharmaceutical company based in La Jolla, California, that develops drug candidates for serious illnesses involving inflammation and damage to tissue cells. Its drugs work by blocking CRAC channels, which play a role in immune and inflammatory signaling. Its lead candidate, Auxora, is an intravenous treatment that has been studied in acute care settings such as acute pancreatitis and kidney injury. The company is also researching the approach for other conditions, including pulmonary arterial hypertension. Its products are still in development and are not yet approved for sale, and they are intended for hospital and specialist use.

Headquarters
La Jolla, CA